While the BCR::ABL1 fusion gene is paramount in CML, this is not the case for BCR::ABL1 negative MPN which encompass a group of clonal haematopoietic stem cell disorders that share some similarities besides having distinct clinical presentations. This evidence concerns the gene BCR and myeloproliferative neoplasm.